Arab World vs Zimbabwe: Access to anti-retroviral drugs, male
Arab World
49.3%
in 2024
Zimbabwe
89.0%
in 2024
Arab World rank
16th
Zimbabwe rank
17th
Access to anti-retroviral drugs, male over time
- Arab World
- Zimbabwe
How they compare
Zimbabwe currently reports 89.0% against 49.3% in Arab World, a difference of 39.7%.
That makes Zimbabwe's figure about 1.8 times Arab World's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Arab World ahead.
Arab World ranks 16th and Zimbabwe ranks 17th of 19 groups.
Across the 3 decades both report, Arab World averaged higher in 1 and Zimbabwe in 2.
Head to head by decade
| Decade | Arab World | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.9% | 4.1% | 2.8% | Arab World |
| 2010s | 24.3% | 52.9% | 28.6% | Zimbabwe |
| 2020s | 44.2% | 88.4% | 44.2% | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Arab World or Zimbabwe?
- Zimbabwe, at 89.0% against 49.3% in Arab World as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Arab World and Zimbabwe?
- 39.7%, with Zimbabwe ahead.
- How many years of comparable data are there for Arab World and Zimbabwe?
- 25 years are reported by both, from 2000 to 2024.
- How do Arab World and Zimbabwe rank globally for access to anti-retroviral drugs, male?
- Arab World ranks 16th and Zimbabwe ranks 17th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.